Skip to Main Content

Try STAT+ TODAY

Medicaid

Most Read

First Opinion David C. Grabowski, Marilyn Rantz and Jasmine L. Travers

Report: U.S. nursing home care is ineffective, inefficient, inequitable, fragmented, and unsustainable

First Opinion Constantinos Michaelidis and Candra Szymanski

Home care instead of hospital care: Congress should extend a crucial waiver

First Opinion Amol Navathe, Risa Lavizzo-Mourey and Joshua Liao

How to fix the two-tier U.S. health payment system

First Opinion Ge Bai and David A. Hyman

Nonprofit hospitals’ community benefits should square with their tax exemptions. They often don’t

Politics Nicholas Florko

Oregon wants to get out of covering drugs like Aduhelm in Medicaid

Health Tech Erin Brodwin

5 health tech startups targeting the Medicaid population to watch

First Opinion Erin E. Trish, Eugene Lin and Matthew Fiedler

Congress should end dialysis companies’ third-party games with insurance coverage

First Opinion Divya Dethier, Megan L. Evans and Erin Tracy Bradley

Medicaid needs to change its archaic rules for women seeking permanent contraception

All Coverage

Hospitals Bob Herman

How North Carolina hospitals justify thwarting Medicaid expansion

First Opinion Maureen Testoni

Pursuit of profits is driving drug companies to break the 340B law

advertisement

First Opinion Jesse Gubb

Making Medicare, Medicaid innovation tests voluntary undermines evaluation opportunities

First Opinion Gerard Vitti

Averting the looming purge of people from Medicaid

Pharmalot Ed Silverman

A looming decision on Medicare coverage for Biogen’s Alzheimer’s drug could shock state Medicaid programs

First Opinion Vangela M. Wade

People in states without Medicaid expansion can’t wait any longer to build back better

First Opinion Matt Salo

Much Adu(helm) about nothing: New Alzheimer’s drug threatens state Medicaid budgets

First Opinion Aytan Y. Bellin

My aunt’s ‘Kafkaesque journey’ to get the home care she needs

Pharmalot Ed Silverman

Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year

Pharmalot Ed Silverman

Centene to pay $143 million to two states to settle allegations of overcharging Medicaid

Politics Rachel Cohrs

Biden’s Medicaid pressure tactics could put his team at odds with hospitals

Exclusive Rachel Cohrs and Lev Facher

Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver

Pharmalot Ed Silverman

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Pharmalot Ed Silverman

Tennessee to become the first state to run a closed Medicaid drug formulary

Health Tech Casey Ross

Health tech’s newest unicorn is running toward Medicaid patients long marginalized in medicine

First Opinion Andrey Ostrovsky

Advice for the next CMS administrator’s first 100 days

First Opinion David C. Mulligan

CMS’s new rules on organ donation and transplantation ‘will bring chaos’

First Opinion Michael Hochman and Michelle Levander

Create a scorecard to help make safety-net providers accountable to patients and the public

First Opinion Eric Letsinger and Alison Rein

Invest in community-based organizations to put health dollars where they are really needed

STAT+ Conversations Casey Ross

‘I can’t imagine going back’: Medicare leader calls for expanded telehealth access after Covid-19

Pharmalot Ed Silverman

Mallinckrodt loses a court case and is on the hook for $650 million in overdue Medicaid rebates

First Opinion Eric Schneider

Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care

First Opinion Wendy E. Parmet

Trump’s immigration policies will make the coronavirus pandemic worse

Pharmalot Ed Silverman

Justice Department sues Mallinckrodt over ‘hundreds of millions of dollars’ in Medicaid rebates

Pharmalot Ed Silverman

PBMs favor their own pharmacies in the Florida Medicaid program